An underground market for unapproved slimming medications is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.
Experimental Treatment Gaining Traction Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to contact these profiles privately for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting customers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Professionals Voice Worries
However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.
Some professionals said the demand for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, advertising, and customer regulations, risking fines, prosecution or prison.
Service Reaction and Material Removal
Based on TikTok, the service has removed violative content and banned associated keywords and query recommendations. The company said it was committed to keeping the platform secure and investing in strengthening enforcement strategies.
Digital Trading Activities
Research also found groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, populated with photos of weight loss, glowing reviews and step-by-step guides for mixing or administering at residence.
Within moments of joining one community, a vendor posted WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about body mass, health issues or previous experience.
Item Information and Costs
Inside these communities, messages display dark colored packages with Royal Mail labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service said it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has previously seen individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose users to potentially significant medical dangers”.
